Get the Stockscreener App
2.37
4.13%
-0.05
Vor Biopharma Inc stock is traded at $2.37, with a volume of 1.04M.
It is down -4.13% in the last 24 hours and up +118.87% over the past month.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
See More
Previous Close:
$2.42
Open:
$2.46
24h Volume:
1.04M
Relative Volume:
0.06
Market Cap:
$293.65M
Revenue:
-
Net Income/Loss:
$-112.46M
P/E Ratio:
-1.4451
EPS:
-1.64
Net Cash Flow:
$-99.89M
1W Performance:
+13.17%
1M Performance:
+118.87%
6M Performance:
+68.12%
1Y Performance:
+139.18%
1-Day Range:
$2.30
$2.49
1-Week Range:
$2.03
$2.56
52-Week Range:
$0.1311
$3.29
Vor Biopharma Inc Stock (VOR) Company Profile
Name
Vor Biopharma Inc
Sector
Industry
Phone
617-655-6580
Address
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Compare VOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
2.35 | 274.91M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.08 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.20 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.32 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
593.25 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
300.45 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-30-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-26-22 | Initiated | Wedbush | Outperform |
| Apr-27-22 | Initiated | Goldman | Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-21 | Initiated | Robert W. Baird | Outperform |
| Dec-02-21 | Initiated | Oppenheimer | Outperform |
| Oct-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Mar-03-21 | Initiated | Evercore ISI | Outperform |
| Mar-02-21 | Initiated | Goldman | Sell |
| Mar-02-21 | Initiated | Stifel | Buy |
View All
Vor Biopharma Inc Stock (VOR) Latest News
These 10 Stocks are Winning Big - Insider Monkey
Vor Biopharma Shares Soar After Strategic Appointments in Leadership - StocksToTrade
How volatile is Vor Biopharma Inc. stock compared to the marketBreakthrough stock performance - jammulinksnews.com
Does Vor Biopharma Inc. stock perform well during market downturnsMaximize your portfolio’s growth potential - jammulinksnews.com
What are analysts’ price targets for Vor Biopharma Inc. in the next 12 monthsGet timely alerts on market opportunities - jammulinksnews.com
What catalysts could drive Vor Biopharma Inc. stock higher in 2025Unstoppable investment returns - jammulinksnews.com
What markets is Vor Biopharma Inc. expanding into Is DMAC stock a good long term investment option - jammulinksnews.com
What are the latest earnings results for Vor Biopharma Inc.Unlock real-time stock alerts for quick profits - jammulinksnews.com
How Efficient Is Vor Biopharma Inc. at Controlling Operating CostsDefensive Stock Picks with Upside - metal.it
What are the technical indicators suggesting about Vor Biopharma Inc.Free Market Volatility Navigation Tips - jammulinksnews.com
Should I hold or sell Vor Biopharma Inc. stock in 2025Achieve superior returns with professional insights - jammulinksnews.com
Published on: 2025-07-27 20:45:01 - jammulinksnews.com
When is Vor Biopharma Inc. stock expected to show significant growthGet real-time alerts on top-performing stocks - jammulinksnews.com
Published on: 2025-07-27 15:05:50 - jammulinksnews.com
Why Vor Biopharma Inc. stock attracts strong analyst attentionFree Smart Investment Opportunities - metal.it
Is Vor Biopharma Inc. a good long term investmentOverwhelming profit margins - PrintWeekIndia
Vor Biopharma Inc. Stock Analysis and ForecastMassive profits - PrintWeekIndia
Vor Bio appoints Sandy Mahatme as CFO - MSN
What analysts say about Vor Biopharma Inc. stockFree Technical Analysis Support - PrintWeekIndia
What drives Vor Biopharma Inc. stock priceFree Stock Selection - PrintWeekIndia
Vor Biopharma Announces Key Leadership Changes - TipRanks
Vor Biopharma Inc.'s (NASDAQ:VOR) top holders are insiders and they are likely disappointed by the recent 14% drop - Yahoo Finance
H.C. Wainwright Upgrades Vor Biopharma (VOR) to a Buy, Sets a $3 Price Target - MSN
Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors - Stock Titan
Vor Biopharma's Strategic Turnaround and the Case for Immediate Investment - AInvest
Vor Biopharma Inc Stock (VOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.60%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):